Epigallocatechin Gallate.

Cavanah and colleagues ran a randomised controlled trial in which curcumin and EGCG were supplemented together and the combination was the tested intervention. Both are polyphenols with poor oral bioavailability and overlapping conjugation routes, which is the usual rationale for combining them. This is a combination that has actually been studied as a combination rather than assembled from two separate literatures.

The galloyl group on EGCG binds ferric iron avidly, forming a complex in the gut lumen that is not absorbed. This is the long-standing reason tea taken with a meal lowers non-heme iron uptake from that meal. The co-occurrence index flags the pair as antagonistic, which matches the chemistry.

Ascorbate reduces ferric to ferrous iron and forms a soluble chelate, which partly offsets the binding EGCG imposes on non-heme iron. Ascorbate also lowers the pH-driven auto-oxidation that degrades catechins in solution, which is why it appears in green tea beverage formulations. Two separate effects, both established chemistry.

EGCG binds divalent zinc through its catechol and galloyl hydroxyls in the same way it binds iron. Dosing a zinc supplement with a strong green tea extract lowers what is available for uptake from that dose. Separating them by a couple of hours is ordinary practice.

Caffeine and EGCG occur together in the leaf and are usually taken together in whole green tea extracts. Caffeine blocks adenosine receptors and raises cyclic AMP, while catechins slow catechol-O-methyltransferase, which degrades noradrenaline; the two act on the same signalling cascade at different points. Most human thermogenesis work on green tea used the combination rather than isolated EGCG, so results from those studies belong to the pair.

Theanine is the dominant free amino acid in tea leaf and travels with EGCG in any whole-leaf extract. Its own activity is on glutamate-family receptor signalling and it is unrelated to the catechin chemistry. The pairing matters because a green tea extract is a mixture and results attributed to EGCG may belong to the matrix.

Galloylated catechins bind proline-rich and globular milk proteins through hydrogen bonding and hydrophobic contact. Adding milk protein to a catechin drink lowers the free catechin fraction available for absorption. The effect is the basis of the long-running question about tea taken with milk.

Casein micelles bind galloylated catechins strongly, and the bound fraction is released only as the protein is digested. This shifts where and when catechin appears in the gut rather than destroying it. In a formulation it means a catechin dose in a protein matrix does not behave like the same dose in water.

Quercetin and EGCG are both substrates for UDP-glucuronosyltransferase and sulfotransferase and both interact with efflux transporters in the enterocyte. Competing for the same clearance machinery raises the exposure of whichever is present, which is the usual rationale for combining them. The size of the shift in people has not been established for this pair.

EGCG's low systemic exposure comes largely from rapid glucuronidation and methylation, not from poor uptake. Piperine slows glucuronidation and is added to polyphenol formulations for that reason. The mechanism is established for piperine generally; the magnitude for EGCG specifically is not.

Alpha-tocopherol works in the lipid phase of membranes and catechins in the aqueous phase, and the tocopheroxyl radical can be reduced back by aqueous-phase reductants. The pairing is complementary by compartment rather than duplicative. This is network chemistry, not an outcome measured in people.

EGCG and its oxidation products are conjugated with glutathione by glutathione S-transferases, which is one of the routes by which the molecule is cleared. High catechin exposure consumes glutathione in that reaction. The relationship runs both ways and is one reason cell-culture results at high catechin concentrations do not transfer to whole-body dosing.

N-acetylcysteine supplies the rate-limiting cysteine for glutathione synthesis, and glutathione conjugation clears catechin oxidation products. Pairing them supports the pathway that handles the catechin rather than the catechin's own activity. No human study has tested the two together.

EGCG inhibits dihydrofolate reductase in cell-free and cell-culture systems, the enzyme that regenerates tetrahydrofolate. Whether ordinary supplement doses do this in people has not been established, so it belongs as a flag rather than a finding. It is worth noting where a folate supplement and a high-dose catechin extract are taken together.

EGCG is the single largest catechin in a standard green tea extract and is the compound most extracts are standardised against. Almost all human data attributed to EGCG were generated with an extract that also carried caffeine, theanine and the other catechins. Reading extract data as isolated-EGCG data overstates what has been measured.

Long-chain omega-3 fatty acids are highly oxidisable and sit in the lipid phase, where a water-soluble catechin cannot reach them directly. The pairing appears in formulations on the general logic of covering both phases. It is a formulation rationale, not a measured combination effect.